TSE:4568Pharmaceuticals
Assessing Daiichi Sankyo Company (TSE:4568) Valuation After VANFLYTA Distribution Agreement With GENESIS Pharma
Why this VANFLYTA agreement matters for Daiichi Sankyo Company (TSE:4568)
Daiichi Sankyo Company (TSE:4568) drew investor attention after signing an exclusive license and supply agreement with GENESIS Pharma to distribute and commercialize VANFLYTA across 13 Central and Eastern European markets.
The deal extends access to quizartinib for adult patients with newly diagnosed FLT3 ITD positive acute myeloid leukemia, using GENESIS Pharma’s regional reach, while Daiichi Sankyo retains...